BIOMAT Database Logo BIOMAT Database Logo

Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. 1989

H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse

Reported are the results of a retrospective study of 3156 patients who were treated at the Queen Saovabha Memorial Institute, Bangkok, with equine rabies immune globulin (ERIG). Only 51 patients (1.6%) exhibited serum-sickness-like reactions, none of which persisted for more than a week, and only 8 of these patients (15%) were treated with a short course of steroids. One patient, whose skin test was negative, had an immediate anaphylactic reaction to ERIG that responded to parenteral therapy with epinephrine and hydrocortisone sodium succinate. Serum-sickness-like reactions were more frequent among females and over 21-year-olds but were exceedingly rare (0.086%) among children under 10 years of age.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Safety of equine rabies immune globulin.
August 1989, Vaccine,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Human rabies immune globulin.
September 1969, Public health reports (Washington, D.C. : 1896),
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin.
December 2003, Biologicals : journal of the International Association of Biological Standardization,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Equine rabies immune globulin: a product with an undeserved poor reputation.
February 1990, The American journal of tropical medicine and hygiene,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Postexposure rabies prophylaxis with human rabies immune globulin.
January 1974, JAMA,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Value of skin testing for predicting reactions to equine rabies immune globulin.
September 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Rabies immune globulin (human) in the prevention of rabies.
January 1976, American journal of hospital pharmacy,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Clinical use of human globulin immune to rabies virus.
June 1976, The Journal of infectious diseases,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine--Thailand.
November 1987, MMWR. Morbidity and mortality weekly report,
H Wilde, and P Chomchey, and P Punyaratabandhu, and P Phanupak, and S Chutivongse
A clinical study of Merieux human rabies immune globulin.
October 1982, Journal of biological standardization,
Copied contents to your clipboard!